Overview
Module 4: Signal Management covers GVP Modules IX and X. New safety signals may emerge at any time following product launch and must be evaluated for relative risk, medical importance, and likelihood of occurrence. Signal Management is, therefore, one of the crucial “routine” Pharmacovigilance activities. Approaches to Signal Management using qualitative and quantitative methods will be illustrated in a workshop with examples as well as general considerations on signal management in the EEA.
- Module 1: Post-Marketing
- Module 2: Regulatory Aspects in Pharmacovigilance
- Module 3: Risk Management
Program Committee
-
Wendy Huisman, PharmD Director
Vigifit, Netherlands -
Fakhredin Sayed Tabatabaei, MD, PhD Senior Assessor
MEB, Netherlands
Have an account?